{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:22:21Z","timestamp":1775244141883,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Merck (US)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2414-9","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T14:09:49Z","timestamp":1493734189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane\/tazobactam"],"prefix":"10.1186","volume":"17","author":[{"given":"Myra W.","family":"Popejoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Huntington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"2414_CR1","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jama.2014.11494","volume":"312","author":"LS Geiss","year":"2014","unstructured":"Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014;312:1218\u201326.","journal-title":"JAMA"},{"key":"2414_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants. Lancet. 2016;387:1513\u201330.","journal-title":"Lancet"},{"key":"2414_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00125-006-0570-3","volume":"50","author":"T Benfield","year":"2007","unstructured":"Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50:549\u201354.","journal-title":"Diabetologia"},{"key":"2414_CR4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diacare.26.2.510","volume":"26","author":"BR Shah","year":"2003","unstructured":"Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510\u20133.","journal-title":"Diabetes Care"},{"key":"2414_CR5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.2337\/diacare.24.6.1044","volume":"24","author":"AG Bertoni","year":"2001","unstructured":"Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care. 2001;24:1044\u20139.","journal-title":"Diabetes Care"},{"key":"2414_CR6","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2215\/CJN.01290308","volume":"3","author":"LS Dalrymple","year":"2008","unstructured":"Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1487\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2414_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000330673","volume":"34","author":"HE Wang","year":"2011","unstructured":"Wang HE, Gamboa C, Warnock DG, Muntner P. Chronic kidney disease and risk of death from infection. Am J Nephrol. 2011;34:330\u20136.","journal-title":"Am J Nephrol"},{"key":"2414_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","volume":"74","author":"GG Zhanel","year":"2014","unstructured":"Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F, et al. Ceftolozane\/tazobactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli. Drugs. 2014;74:31\u201351.","journal-title":"Drugs"},{"key":"2414_CR9","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1128\/AAC.02151-13","volume":"58","author":"M Wooley","year":"2014","unstructured":"Wooley M, Miller B, Krishna G, Hershberger E, Chandorkar G. Impact of renal function on the pharmacokinetics and safety of ceftolozane-tazobactam. Antimicrob Agents Chemother. 2014;58:2249\u201355.","journal-title":"Antimicrob Agents Chemother"},{"key":"2414_CR10","unstructured":"Zerbaxa (ceftolozane and tazobactam) [prescribing information]. Whitehouse Station; Merck Sharpe & Dohme Corp.; 2015."},{"key":"2414_CR11","unstructured":"Zerbaxa (ceftolozane and tazobactam) [summary of product characteristics]. Hoddesdon, Hertforshire; Merck Sharpe & Dohme Ltd.; 2016."},{"key":"2414_CR12","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cid\/civ097","volume":"60","author":"J Solomkin","year":"2015","unstructured":"Solomkin J, Hershberger E, Miller B, Popejoy M, Friedland I, Steenbergen J, et al. Ceftolozane\/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI). Clin Infect Dis. 2015;60:1462\u201371.","journal-title":"Clin Infect Dis"},{"key":"2414_CR13","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(14)62220-0","volume":"385","author":"FM Wagenlehner","year":"2015","unstructured":"Wagenlehner FM, Umeh O, Steenbergen J, Yuan G, Darouiche RO. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Lancet. 2015;385:1949\u201356.","journal-title":"Lancet"},{"key":"2414_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/sim.4780040211","volume":"4","author":"O Miettinen","year":"1985","unstructured":"Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4:213\u201326.","journal-title":"Stat Med"},{"issue":"suppl 1","key":"2414_CR15","first-page":"S27","volume":"16","author":"J Casqueiro","year":"2012","unstructured":"Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(suppl 1):S27\u201336.","journal-title":"Indian J Endocrinol Metab"},{"key":"2414_CR16","unstructured":"Grabe M, Bjerklund-Johansen TE, Botto H, Wullt B, \u00c7ek M, Naber KG, et al. Guidelines on urological infections. 2012. http:\/\/uroweb.org\/wp-content\/uploads\/19-Urological-infections_LR2.pdf . Accessed 1 May 2017."},{"key":"2414_CR17","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1089\/sur.2012.195","volume":"14","author":"C-C Tsai","year":"2013","unstructured":"Tsai C-C, Lee J-J, Liu TP, Ko W-C, Wu C-J, Pan C-F, et al. Effects of age and diabetes mellitus on clinical outcomes in patients with peritoneal dialysis-related peritonitis. Surg Infect (Larchmt). 2013;14:540\u20136.","journal-title":"Surg Infect (Larchmt)"},{"key":"2414_CR18","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1086\/427699","volume":"40","author":"RW Thomsen","year":"2005","unstructured":"Thomsen RW, Hundborg HH, Lervang H-H, Johnsen SP, Sch\u00f8nheyder HC, S\u00f8rensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis. 2005;40:628\u201331.","journal-title":"Clin Infect Dis"},{"key":"2414_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1464-410X.2006.06222.x","volume":"98","author":"PE Pertel","year":"2006","unstructured":"Pertel PE, Haverstock D. Risk factors for a poor outcome after therapy for acute pyelonephritis. BJU Int. 2006;98:141\u20137.","journal-title":"BJU Int"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2414-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T21:33:12Z","timestamp":1569187992000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2414-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2414"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2414-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]},"article-number":"316"}}